Pain management services in palliative care: a national survey

Introduction: The effective management of pain requires a multidisciplinary approach. Previous studies have suggested that around 8% of cancer patients will require interventional techniques from an anaesthetist with special interest in pain management to maximize pain control, although this percentage may increase in the cohort of patients with difficult pain syndromes under the care of specialist palliative care services. We wished to determine the experiences and views of other palliative care physicians with regard to input from specialists in pain management. Method: A postal questionnaire was sent to the consultant members of the Association of Palliative Medicine. Results: Most respondents had access to ‘as-required’ anaesthetist consultations with 72% of respondents feeling that the frequency of consultation was adequate. However, over half of the respondents had used the services of a pain management specialist less than four times in the past year and a quarter of respondents had not been involved in a joint consultation with an anaesthetist in the past year. All respondents felt that the pain management specialist's role included advice on technical procedures but less than 25% felt that their role should extend to advice on prescribing analgesics. Discussion: There are likely to be several reasons for this apparent underutilization of specialist anaesthetist/pain management services. This survey has identified possible factors including lack of formal arrangements, lack of suitable experience and the attitudes of palliative medicine consultants.

[1]  J. van Egmond,et al.  Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. , 1999, The Clinical journal of pain.

[2]  S. D. Pen Complications of neuraxial infusion in cancer patients. , 1999 .

[3]  M. Jackson,et al.  Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. , 1999, Thorax.

[4]  L. Radbruch,et al.  Assessment and treatment of neuropathic cancer pain following WHO guidelines , 1999, Pain.

[5]  S. Mercadante,et al.  The inappropriate use of the epidural route in cancer pain. , 1997, Journal of pain and symptom management.

[6]  S. Ho,et al.  Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[7]  John Lynch,et al.  Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study , 1995, Pain.

[8]  J. Eisenach,et al.  Epidural clonidine analgesia for intractable cancer pain , 1995, Pain.

[9]  T. Chalmers,et al.  Neurolytic Celiac Plexus Block for Treatment of Cancer Pain: A Meta-Analysis , 1995, Anesthesia and analgesia.

[10]  J. Plummer,et al.  Epidural opiates and local anaesthetics for the management of cancer pain , 1992, Pain.

[11]  N. Janjan,et al.  Epidural opiates and local anesthetics for the management of cancer pain , 1991, Pain.

[12]  S. Einarsson,et al.  Long‐term intrathecal morphine and bupivacaine in “refractory” cancer pain. I. Results from the first series of 52 patients , 1991, Acta anaesthesiologica Scandinavica.

[13]  S. Ahmedzai,et al.  What do hospices do? A survey of hospices in the United Kingdom and Republic of Ireland. , 1990, BMJ.

[14]  S. Schug,et al.  Cancer pain management according to WHO analgesic guidelines. , 1990, Journal of pain and symptom management.

[15]  A. Caraceni,et al.  A validation study of the WHO method for cancer pain relief , 1987, Cancer.

[16]  F. Magora,et al.  EPIDURAL MORPHINE IN TREATMENT OF PAIN , 1979, The Lancet.

[17]  G. Owens Control of pain in patients with cancer. , 1967, The Journal-lancet.

[18]  S. D. Du Pen Complications of neuraxial infusion in cancer patients. , 1999, Oncology.

[19]  S. Mercadante Outcome and complications of epidural analgesia in patients with chronic cancer pain , 1999, Cancer.